No. of Pages: 88 | Report Code: BMIRE00031087 | Category: Life Sciences
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2.1 Key Insights
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4.1 North America Vaccine Adjuvants Market – Key Market Dynamics
4.2 Market Drivers
4.2.1 Rising Number of Infectious Disease Outbreaks and Pandemic
4.2.2 Approvals of Veterinary Vaccine Adjuvants
4.3 Market Restraints
4.3.1 Product Recalls and Adverse Effects
4.4 Market Opportunities
4.4.1 Support for Developments in Adjuvant Studies and Collaborative Efforts for Product Launches
4.4.2 Advancements in Biotechnology and Immunology
4.5 Future Trends
4.5.1 Technological Advancements
4.6 Impact of Drivers and Restraints:
5.1 North America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
5.2 North America Vaccine Adjuvants Market Forecast and Analysis
6.1 Overview
6.2 Mineral Salt Adjuvant
6.2.1 Overview
6.2.2 Mineral Salt Adjuvant: North America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
6.3 Emulsion Adjuvant
6.3.1 Overview
6.3.2 Emulsion Adjuvant: North America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Liposome Adjuvant
6.4.1 Overview
6.4.2 Liposome Adjuvant: North America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Others
6.5.1 Overview
6.5.2 Others: North America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
7.1 Human Vaccine Adjuvant
7.1.1 Overview
7.1.2 Human Vaccine Adjuvant: North America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
7.2 Veterinary Vaccine Adjuvant
7.2.1 Overview
7.2.2 Veterinary Vaccine Adjuvant: North America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1 North America
8.1.1 North America Vaccine Adjuvants Market – Revenue and Forecast Analysis – by Country
8.1.1.1 United States: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.1.1 Overview
8.1.1.1.2 United States: Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.1.3 United States: Vaccine Adjuvants Market Breakdown, by Adjuvant Class
8.1.1.1.4 United States: Vaccine Adjuvants Market Breakdown, by Type
8.1.1.2 Canada: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.2.1 Overview
8.1.1.2.2 Canada: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.2.3 Canada: Vaccine Adjuvants Market Breakdown, by Adjuvant Class
8.1.1.2.4 Canada: Vaccine Adjuvants Market Breakdown, by Type
8.1.1.3 Mexico: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.3.1 Overview
8.1.1.3.2 Mexico: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.3.3 Mexico: Vaccine Adjuvants Market Breakdown, by Adjuvant Class
8.1.1.3.4 Mexico: Vaccine Adjuvants Market Breakdown, by Type
9.1 Overview
9.2 Growth Strategies in the Global Vaccine Adjuvants Market
9.3 Organic Developments
9.3.1 Overview
9.4 Inorganic Developments
9.4.1 Overview
10.1 SPI Pharma Inc
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 GSK Plc
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 CSL Ltd
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Seppic SA
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Hawaii Biotech Inc
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Dynavax Technologies Corp
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 InvivoGen SAS
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Croda International Plc
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Novavax Inc
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Phibro Animal Health Corp
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
11.1 About The Insight Partners
Table 1. North America Vaccine Adjuvants Market Segmentation
Table 2. North America Vaccine Adjuvants Market Revenue and Forecasts To 2030 (US$ Million)
Table 3. United States: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class
Table 4. United States: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 5. Canada: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class
Table 6. Canada: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 7. Mexico: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class
Table 8. Mexico: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 9. Organic Developments Done by Companies
Table 10. Inorganic Developments Done by Companies
Figure 1. North America Vaccine Adjuvants Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. North America Vaccine Adjuvants Market Revenue (US$ Million), 2022–2030
Figure 4. North America Vaccine Adjuvants Market Share (%) – by Adjuvant Class (2022 and 2030)
Figure 5. Mineral Salt Adjuvant: North America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 6. Emulsion Adjuvant: North America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Liposome Adjuvant: North America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: North America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. North America Vaccine Adjuvants Market Share (%) – by Type (2022 and 2030)
Figure 10. Human Vaccine Adjuvant: North America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Veterinary Vaccine Adjuvant: North America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. North America Vaccine Adjuvants Market by Key Countries – Revenue (2022) US$ Million
Figure 13. North America Vaccine Adjuvants Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 14. United States: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)
Figure 15. Canada: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)
Figure 16. Mexico: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)
Figure 17. Growth Strategies in the Vaccine Adjuvants Market
E 1803, Panchshil Towers, Vagholi, Haveli, Pune- 412207, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Vaccine Adjuvants Market
